Insights on Low Platelet Count from Anshul Gupta – Aastha Hospice
Aastha Hospice shared a post on X:
“Understanding Low Platelet Count: Insights from Dr. Anshul Gupta, Senior Hemato-Oncologist.
Low platelet count (thrombocytopenia) is a common cause of panic among patients.
In a discussion with Dr. Abhishek Shukla, Dr. Anshul Gupta, Senior Hemato-Oncologist, provided key clinical perspectives on managing this condition.
When evaluating a patient with low platelets, doctors consider three primary factors:
- Age: Special attention is required for children (younger than 18 years) and elderly individuals (older than 60 years), where a low count might indicate underlying conditions or bone marrow issues rather than simple Immune Thrombocytopenia (ITP).
- Clinical Appearance: Assessing whether the patient looks acutely ill or remains symptomatic-free and mobile.
- Complete Blood Count (CBC) Profile: Checking whether other blood cell lines (WBCs and Hemoglobin) are also affected.
In ITP or post-viral cases (like Dengue), counts above 30,000 generally do not require immediate intervention, as antibody levels usually subside over time. If platelets drop below 20,000 or bleeding occurs (e.g., from the mouth, nose, or in urine), prompt evaluation and possible admission are needed.
In Dengue, repetitive platelet transfusions are often unnecessary unless clinically indicated. Regarding treatment, popular remedies like Carica papaya extract lack definitive clinical evidence.
While specific medications such as Eltrombopag or Romiplostim exist to raise platelet counts, they must be used strictly under expert guidance; unnecessary use can cause dangerously high platelet levels and severe risks like arterial thrombosis.
Key Takeaway:
Do not panic over a low report. Consult a physician or hematologist to treat the underlying cause rather than self-medicating.”
Proceed to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 20, 2026, 19:46Haseeb Raza: A Practical Guide to Managing Bleeding on Anticoagulant Therapy
-
Aug 20, 2026, 19:44Harshi Peiris: 2026 Cholesterol Guidelines Bring Earlier and More Precise Risk Assessment
-
Aug 20, 2026, 19:39Mostafa Faisal: Eltrombopag and Cyclosporine A for the Treatment of Moderate Aplastic Anemia
-
Aug 20, 2026, 18:54CDC’s Sickle Cell Data Collection Program Provides Key Insights Into Patient Care – ASH
-
Aug 20, 2026, 18:15Rishabh Jain: MPNs May Finally Be Moving from Disease Control to Clonal Eradication
-
Aug 20, 2026, 18:01Ahmed Abdulrahman Al Mathehaji: LMWH Is Preferred Despite Elevated INR in Decompensated Cirrhosis
-
Aug 20, 2026, 17:43Moazzam Shahzad: Haplo-HCT With PTCy Offers a Robust Alternative to MSD-HCT
-
Aug 20, 2026, 17:04Celebrating the 2026 ISTH Reach-the-World Fellowship Recipients – ISTH
-
Aug 20, 2026, 16:13Geraldine Walsh: Exploring Blood Components in Transfusion Today